This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2009-2013.
Company Filing History:
Years Active: 2009-2013
Title: Michael N Zimmerman: Innovator in Hydroxylase Inhibitors
Introduction
Michael N Zimmerman is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of hydroxylase inhibitors. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases.
Latest Patents
Zimmerman's latest patents include N-substituted glycine derivatives that act as hydroxylase inhibitors. The invention described in these patents relates to certain pyridazinedione N-substituted glycine derivatives, which are antagonists of HIF prolyl hydroxylases. These compounds are particularly useful for treating diseases that benefit from the inhibition of this enzyme, with anemia being a prime example.
Career Highlights
Throughout his career, Michael N Zimmerman has worked with prominent companies in the pharmaceutical industry. He has been associated with SmithKline Beecham Corporation and GlaxoSmithKline LLC, where he contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing therapeutic options.
Collaborations
Zimmerman has collaborated with several professionals in his field, including Antony N Shaw and Kevin J Duffy. These collaborations have fostered innovation and have led to the successful development of new therapeutic agents.
Conclusion
Michael N Zimmerman is a distinguished inventor whose work in hydroxylase inhibitors has the potential to impact the treatment of anemia and other related diseases. His contributions to the pharmaceutical industry highlight the importance of innovation in addressing medical challenges.